Idera Pharmaceuticals, Inc.

Idera Pharmaceuticals, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Idera Pharmaceuticals, Inc. is not a good value stock. Idera Pharmaceuticals, Inc. is not very popular among insiders. Idera Pharmaceuticals, Inc. is a mediocre stock to choose.
Log in to see more information.
Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clin...

News